Compared to other upregulated molecules identified in the sequencing profiles of patients with advanced-stage PCa (Supplementary Table 1), higher KHDC4 transcript levels were significantly associated with poorer overall survival and disease-free survival outcomes, underscoring KHDC4 as a valuable prognostic factor in PCa (Figure 1). Here, KHDC4 is linked to posterior cortical atrophy.